Destruction of WiDr multicellular tumor spheroids with the novel thymidylate synthase inhibitor 1843U89 at physiological thymidine concentrations-Reference-Cited by-同舟云学术

Destruction of WiDr multicellular tumor spheroids with the novel thymidylate synthase inhibitor 1843U89 at physiological thymidine concentrations

Published:1994 Issue:6 Volume:33 Page:455-459
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Banks Sheila D.,Waters Kathleen A.,Barrett Linda L.,Dickerson Scott,Pendergast William,Smith Gary K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00686500.pdf

Reference16 articles.

1. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177?184

2. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ, Mittelman A (1987) A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5: 1559?1565

3. Newell DR, Alison DL, Calvert AH, Harrap KR, Jarman M, Jones TR, Manteuffel-Cymborowska M, O'Connor P (1986) Pharmacokinetics of the thymidylate synthase inhibitorN 10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse. Cancer Treat Rep 70: 971?979

4. Alison DL, Newell DR, Sessa C, Harland SJ, Hart LI, Harrap KR, Calvert AH (1985) The clinical pharmacokinetics of the novel antifolateN 10-propargyl-5,8-dideazafolic acid (CB3717). Cancer Chemother Pharmacol 14: 265?271

5. Judson I, Clarke S, Ward J, Sutcliffe F, Planting A, Spiers J, Smith R, Verweij J (1992) Pharmacokinetics of ICI D1694 following a 15-min infusion in patients with advanced cancer. Proc 28th Annu Meet Am Soc Clin Oncol 11: 117

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance;Drug Resistance Updates;2012-08

2. Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge?;International Journal of Radiation Biology;2007-01

3. Pharmacokinetics, Safety, and Efficacy of a Liposome Encapsulated Thymidylate Synthase Inhibitor, OSI-7904L [(S)-2-[5-[(1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric Acid] in Mice;Journal of Pharmacology and Experimental Therapeutics;2004-02-24

4. GW1843;Antifolate Drugs in Cancer Therapy;1999

5. Increases in Neutral, Mg2+-Dependent and Acidic, Mg2+-Independent Sphingomyelinase Activities Precede Commitment to Apoptosis and Are Not a Consequence of Caspase 3–Like Activity in Molt-4 Cells in Response to Thymidylate Synthase Inhibition by GW1843;Blood;1998-06-01